TY  - JOUR
PY  - 2002//
TI  - Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings
JO  - Emerging infectious diseases
A1  - Jernigan, Daniel B.
A1  - Raghunathan, Pratima L.
A1  - Bell, Beth P.
A1  - Brechner, Ross
A1  - Bresnitz, Eddy A.
A1  - Butler, Jay C.
A1  - Cetron, Marty
A1  - Cohen, Mitch
A1  - Doyle, Timothy
A1  - Fischer, Marc
A1  - Greene, Carolyn
A1  - Griffith, Kevin S.
A1  - Guarner, Jeannette
A1  - Hadler, James L.
A1  - Hayslett, James A.
A1  - Meyer, Richard
A1  - Petersen, Lyle R.
A1  - Phillips, Michael
A1  - Pinner, Robert
A1  - Popovic, Tanja
A1  - Quinn, Conrad P.
A1  - Reefhuis, Jennita
A1  - Reissman, Dori
A1  - Rosenstein, Nancy E.
A1  - Schuchat, Anne
A1  - Shieh, Wun-Ju
A1  - Siegal, Larry
A1  - Swerdlow, David L.
A1  - Tenover, Fred C.
A1  - Traeger, Marc
A1  - Ward, John W.
A1  - Weisfuse, Isaac
A1  - Wiersma, Steven
A1  - Yeskey, Kevin
A1  - Zaki, Sherif
A1  - Ashford, David A.
A1  - Perkins, Bradley A.
A1  - Ostroff, Steve
A1  - Hughes, James
A1  - Fleming, David
A1  - Koplan, Jeffrey P.
A1  - Gerberding, Julie Louise
SP  - 1019
EP  - 1028
VL  - 8
IS  - 10
N2  - In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.<p /> <p>Language: en</p>
LA  - en
SN  - 1080-6040
UR  - http://dx.doi.org/
ID  - ref1
ER  -